Adverse outcomes after single acute methotrexate exposures in pediatric patients are rare

Hannah HaysCentral Ohio Poison Center, Columbus, OH, USA; ;Nationwide Children’s Hospital, Columbus, OH, USA; ;The Ohio State University College of Medicine, Columbus, OH, USA; Correspondence[email protected]

Michael C. BeuhlerCarolinas Poison Center, Charlotte, NC, USA

Henry A. SpillerCentral Ohio Poison Center, Columbus, OH, USA; ;The Ohio State University College of Medicine, Columbus, OH, USA;

http://orcid.org/0000-0002-0121-7055

References

Benson BE, Spyker DA, Troutman WG. TESS-based dose-response using pediatric clonidine exposures. Toxicol Appl Pharmacol. 2006;213:145–151.
PubMed Web of Science ®Google Scholar
Stoller RG, Hande KR, Jacobs SA, et al. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. N Engl J Med. 1977;297:630–634.
PubMed Web of Science ®Google Scholar
Chabner BA, Young RC. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. J Clin Invest. 1973;52:1804–1811.
PubMed Web of Science ®Google Scholar
Chan BS, Dawson AH, Buckley N. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning? Clin Tox. 2017;55:88–96.
PubMed Web of Science ®Google Scholar
Hensley MD, Bebarta VS, Borys DJ. A large case series of acute pediatric methotrexate ingestions: significant clinical effects are rare. Ped Emerg Care. 2016;32:682–684.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Adverse outcomes after single acute methotrexate exposures in pediatric patients are rare

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Adverse outcomes after single acute methotrexate exposures in pediatric patients are rare

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date